Pharmacokinetics of ciprofloxacin in hospitalized geriatric patients: Comparison between nasogastric tube and oral administration

Therapeutic Drug Monitoring

Volumn 35, Issue 5, 2013, Pages 653-656

  Lubart, Emily ^a   Berkovitch, Matitiahu ^b   Leibovitz, Arthur ^a   Britzi, Malka ^c   Soback, Stefan ^c   Bukasov, Yury ^a   Segal, Rafael ^a  

^a Tel Aviv University Sackler Faculty of Medicine   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

ciprofloxacin concentration; geriatric patients; nasogastric tube; orally fed; therapeutic drug monitoring

Indexed keywords

CIPROFLOXACIN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; DRUG BLOOD LEVEL; DYSPHAGIA; FEMALE; GERIATRIC CARE; HEMODYNAMICS; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LONG TERM CARE; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NASOGASTRIC DRUG ADMINISTRATION; PRIORITY JOURNAL; STEADY STATE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; FEMALE; HOSPITALIZATION; HUMANS; INTUBATION, GASTROINTESTINAL; MALE;

EID: 84885020344     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182940426     Document Type: Article

References (30)

1. Gillick M. Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med. 2000;342:206-210
2. Layne KA, Losinski D, Zenner PM, et al. Using the Flewing index of Dysphagia to establish prevalence. Dysphagia. 1989;4:39-42
3. Steele CM, Greenwood C, Ens I, et al. Mealtime difficulties in a home for the aged: Not just dysphagia. Dysphagia. 1997;12:43-50
4. Ciocon JO. Indication for the tube feeding in elderly patients. Dysphagia. 1990;5:1
5. Woolfson AM, Saour JN, Ricketts CR, et al. Prolonged nasogastric tube feeding in critically ill and surgical patients. Postgrad Med J. 1976;52: 678-682
6. Weir RF, Gostin L. Decisions to abate life-sustaining treatment for nonautonomous patients. Ethical standards and legal liability for physicians after Cruzan. JAMA. 1990;264:1846-1853
7. Solomon MZ, O'Donnell L, Jennings B, et al. Decisions near the end of life: Professional views on life-sustaining treatments. Am J Public Health. 1993; 83:14-23
8. O'Brien LA, Sieger EA, Grisso JA, et al. Tube feeding preferences among nursing home residents. J Gen Intern Med. 1997;12:364-371
9. Schneider JS, Ouellette SM. Sucralfate administration via nasogastric tube. N Engl J Med. 1984;310:990
10. Larson C, Cavuto NJ, Flockhart DA, et al. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube. Dig Dis Sci. 1996;41: 475-479
11. Fish DN, Abraham E. Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients. Antimicrob Agents Chemother. 1999;43:1277-1280
12. Lubart E, Berkovitch M, Leibovitz A, et al. Phenytoin blood concentration in hospitalized geriatric patients: Oral versus nasogastric feeding tube administration. Ther Drug Monit. 2010;32:185-188
13. Berkovitch M, Orly D, Leibovitz A, et al. Therapeutic drug monitoring of theophylline in frail elderly patients: Oral compared with nasogastric tube administration. Ther Drug Monit. 2002;24:594-597
14. Bergan T. Pharmacokinetics of fluorinated quinolones. In: Andriole VT, ed. Quinolones. 1988:119-154
15. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, Double-blind trial comparing intravenous ciprofloxacin with imipenemcilastatin. Antimicrob Agents Chemother. 1994;38:547-557
16. Khan GJ, Noe AJ, Beermann D. Liquid chromatographic analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids. J Liq Chromatogr. 1986;9:2897-2919
17. Dickerson RN. Medication administration considerations for patients receiving enteral tube feedings. Hosp Pharm. 2004;39:84-96
18. Nyffeler MS, Frankel E, Hayes E, et al. Drug-nutritient interactions. In: Merritt R, DeLegge MH, Holcombe B, et al, eds. The ASPEN Nutrition Support Practice Manual. 2nd ed. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2005:118-136
19. Belknap DC, Seifert CF, Petermann M. Administration of medication through enteral feeding catheter. Am J Crit Care. 1997;6:382-392
20. Yamaoka K. Methods for Pharmacokinetic Analysis by Personal Computer. 2nd ed. Tokyo, Japan: Nanko-Do Ltd; 1986;145-154
21. Beggs EJ, Robson RA, Saunders DA, et al. The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing. Br J Clin Pharmacol. 2000;49:32-38
22. Gonzales MA, Uribe F, Moisen SD, et al. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1984;26:741-744
23. Cohn SM, Sawyer MD, Burns GA, et al. Enteric absorbtion of ciprofloxacin during tube feeding in the critically ill. J Antimicrob Chemother. 1996;38:871-876
24. Mimoz O, Binter V, Jacolot A, et al. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients. Intensive Care Med. 1998;24:1047-1051
25. Brittain DC, Scully BE, McElrath MJ, et al. The pharmacology of orally administered ciprofloxacin. Drugs Exp Clin Res. 1985;11:339-341
26. Hoffken G, Borner K, Glatzel PD, et al. Reduced enteral absorbtion of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol. 1985;4:345
27. Wingender W, Graefe KH, Gau W, et al. Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. Eur J Clin Microbiol. 1984;3:355-359
28. Yuk JH, Nightingale CH, Quintiliani R, et al. Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition. Diagn Microbiol Infect Dis. 1990; 13:99-102
29. Mueller BA, Brierton DG, Abel SR, et al. Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrob Agents Chemother. 1994;38:2101-2105
30. Debon R, Breilh D, Boselli E, et al. Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: A comparison of two dosages. J Chemother. 2002;14:175-180